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ABSTRACT  
 
Objectives: In early stage psychosis research is the identification of neurobiological 
correlates of vulnerability to schizophrenia an important hurdle.  
Methods: We conducted a systematic review of the neuroimaging publications on 
high-risk subjects with subsequent transition to psychosis (HR-T) and conducted a 
meta-analysis using the Cohen’s d. 
Results: Out of 30 identified studies 25 met the inclusion criteria. sMRI studies 
showed small to medium effect sizes of decreased prefrontal, cingulate, insular and 
cerebellar gray matter volume in HR-T compared to high-risk subjects without 
transition (HR-NT) and reduced temporal cortex in first episode (FE) of psychosis 
subjects compared to HR-T. 
Compared to HR-NT, HR-T subjects showed in functional imaging studies reduced 
brain activation in prefrontal cortex, reduced neuronal density, increased membrane 
turnover in frontal and cingulate cortex and decreased availability of serotonine 
receptors in prefrontal cortex with medium to large effect sizes. 
Conclusions: Despite methodological differences between studies, structural and 
neurochemical abnormalities in prefrontal, anterior cingulate, medial temporal and 
cerebellar cortex might be predictive for development of psychosis within HR 
subjects. 
 
Keywords: psychosis, schizophrenia, high-risk, at risk mental state, transition, brain, 
neuroimaging, systematic review, meta-analysis, fMRI, sMRI, PET, MRS 
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1. INTRODUCTION 
 
Over the past 15 years early clinical intervention in schizophrenia has become a major 
objective of mental health services. While in the beginning, early detection centres 
focused on the early diagnosis of first episode (FE) of schizophrenia, in later years 
these centres have also started preventive interventions. Such strategies are aimed at 
identifying and treating patients before the criteria for a DSM-III R or DSM-IV 
schizophrenia diagnosis are fulfilled and prior to the onset of frank psychosis, a period 
of time broadly termed as high-risk (HR) state for psychosis (for review see (Riecher-
Rossler et al., 2006)). 
Evidence for a high-risk state is emerging, in part because schizophrenia may result 
from a genetic predisposition (Lawrie et al., 2008) and/or gene-neurodevelopmental 
interaction (DeLisi, 2008; Pantelis et al., 2005) leading to defective connections of 
critical brain regions and cytoarchitectural abnormalities which could explain the 
variety of clinical, neurobiological and neuropsychological features occurring before 
the onset of psychosis (Cannon, 2005; Tsuang et al., 2000). 
 
1.1 High-risk research paradigms 
 
Research on the early phase of the disorder may provide important clues to the 
mechanisms underlying schizophrenia, thereby facilitating early diagnosis and 
treatment strategies. In order to investigate the characteristics of liability to psychosis, 
two high-risk research paradigms have recently been developed. Endorsing the 
genetic high-risk approach, putative endophenotypes can be evaluated for association 
with genetic risk for schizophrenia by comparing the unaffected co-twins of patients 
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or the unaffected relatives of patients with normal controls (Baare et al., 2001; 
Hulshoff Pol et al., 2004; Job et al., 2003; Johnson et al., 2003; Lawrie et al., 1999; 
Lawrie et al., 2002; van Erp et al., 2004; van Haren et al., 2004; Whyte et al., 2006).  
Alternatively, ‘close in’ i.e. clinical high-risk approaches are able to identify a group 
at ultra high-risk of psychosis with higher transition rates than those observed in 
studies purely based on genetic inclusion criteria (Cornblatt et al., 2002; McGlashan 
and Johannessen, 1996; Pantelis et al., 2007; Yung et al., 1998). The latter approach, 
focusing on individuals who are considered to be at increased risk for psychotic 
disorders, is based primarily on the presence of clinical symptoms. The strategy aims 
at identifying neural changes occurring prior to the onset of psychosis and may 
improve our ability to predict schizophrenia outcomes based on the combined 
perspectives of both neural and clinical characteristics observed at the baseline 
assessment. 
HR subjects have been shown to present attenuated positive, brief limited intermittent 
(Riecher-Rossler et al., 2007; Riecher-Rossler et al., 2009; Yung et al., 2004), and 
negative (Lencz et al., 2004; Riecher-Rossler et al., 2009) psychotic symptoms and 
mild cognitive deficits (Brewer et al., 2006; Riecher-Rossler et al., 2009). Compared 
to a healthy population, they have a significantly greater probability of developing the 
illness (Riecher-Rossler et al., 2007; Riecher-Rossler et al., 2009; Yung et al., 1998), 
suggesting that specific aspects of prodromal symptoms may represent vulnerability 
markers for developing schizophrenia (Morey et al., 2005). However, there is a high 
level of heterogeneity among inclusion criteria for the high-risk state. Hence, the term 
‘at-risk mental state’ (ARMS) has been suggested instead of the term ‘prodromal’, to 
delineate a sub-threshold syndrome that confers high - but not inevitable - risk for 
development of psychotic disorder in the near future (Yung et al., 1998). 
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1.2 Neuroimaging studies of liability to psychosis 
 
Over the past decade, neuroimaging techniques have been employed to explore the 
neurobiological correlates of an increased liability to psychosis. These methods 
include structural (sMRI) and functional (fMRI, MRS and PET) approaches. 
Structural neuroimaging studies from FE schizophrenia subjects reported small 
reductions in global and regional brain volumes at initial presentation (Steen et al., 
2006), and volume loss over time in those patients who have a deteriorating clinical 
course (DeLisi et al., 1997; Ho et al., 2003; Kasai et al., 2003; Lieberman et al., 
2001). These volume reductions in FE compared to HC subjects resemble 
observations from meta-analytic reviews of chronic schizophrenics compared to HC 
subjects (Glahn et al., 2008; Honea et al., 2005; Vita et al., 2006; Wright et al., 2000). 
Additionally, functional imaging studies indicate that the neurofunctional 
abnormalities during cognitive tasks are qualitatively similar but less severe in HR 
subjects compared to FE patients (Fusar-Poli et al., 2007). However, the onset and the 
time-course of structural and functional alterations are mostly unknown. Indeed, it is 
critical to the understanding of the pathogenesis of these brain changes to clarify their 
onset and the dynamic neurobiological processes underlying the transition from a 
high-risk state to full-blown psychosis.  
 
To address the neurobiological correlates of transition to psychosis, here we have 
reviewed cross-sectional and longitudinal structural and functional imaging studies 
that have compared high-risk subjects with (HR-T) and without (HR-NT) later 
transition to psychosis. With the combination of structural and functional meta-
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analytical results we intend to characterise predictive neuroanatomical and 
neurofunctional abnormalities underlying the transition to psychosis. 
Our hypotheses were: 
1. HR-T subjects would show, even before transition to psychosis, volumetric 
abnormalities relative to HR-NT ones qualitatively similar to those in patients with 
FE schizophrenia. 
2. Neuroanatomical and neurofunctional abnormalities in HR-T and FE subjects 
would be found in similar brain regions (i.e. prefrontal, cingulate and medial temporal 
cortex), but differently strong pronounced. 
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2. METHODS 
 
To achieve the high standard of reporting we have adopted ‘Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses’ (PRISMA) guidelines (Minzenberg et 
al., 2009), the revised QUOROM Statements (Quality Of Reporting Of Meta-
analyses), because our included studies are mostly case-control studies. We then 
performed the quantitative analysis on included studies.  
 
2.1. Selection procedures 
 
2.1.1. Search strategy 
 
Electronic searches were performed in the PUBMED database using the following 
search terms: psychosis, schizophrenia, at-risk mental state, high-risk, neuroimaging, 
brain imaging, magnetic resonance imaging, MRI, functional magnetic resonance, 
fMRI, structural magnetic resonance imaging, sMRI, positron emission tomography, 
PET, proton magnetic resonance spectroscopy, MRS. Two reviewers (RS, SB) 
independently reviewed the database and extracted the data in order to avoid bias or 
error in the selection of articles and by the extraction of data from studies. 
  
 In addition we carefully searched the reference lists of the included articles identified 
in the original search. All reports published until September 2009 were included, 
without any language restriction though all included papers were in English.  
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2.1.2. Selection criteria 
 
Initially, we performed a systematic review and meta-analysis including a description 
of all studies employing neuroimaging to investigate brain structure or function in 
high-risk populations. Then, we hand-searched the papers in order to select studies 
meeting our inclusion criteria: (a) be an original paper in a peer-reviewed journal (b) 
have examined subjects at high-risk of psychosis (as defined in paragraph 2.2.) using 
functional or structural neuroimaging techniques (c) have divided the group of high-
risk subjects into subgroups of HR-T and HR-NT. Imaging studies of high-risk 
subjects that did not perform ‘transition-versus-non-transition-contrasts’ were not 
included. Almost all of included studies are case-controlled studies and they had to 
have control subjects that were matched for age and sex. There is one pilot study 
(Pantelis et al., 2003) and three following studies (Sun et al., 2009; Thompson et al., 
2007; Walterfang et al., 2008) based on the same group of patients without a control 
group of healthy subjects. We have excluded studies that involved participants of less 
than 14 years of age, subjects with other neurological or psychiatric disorders, and/or 
substance abuse disorder (see paragraph 3.2). When the data from a single subject 
sample were reported in separate publications, these were treated as single studies. 
Conversely, a publication that reported two forms of different imaging data from the 
same subjects was considered as two studies.  
 
2.2. Recorded variables 
 
The recorded variables for each article included in the review were: imaging centre 
where the study was performed, type of design or task, gender, mean age of 
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participants, duration of follow-up, transition rate, type of imaging analysis, exposure 
to medications. The primary outcomes of interest were global/regional volumes for 
structural and global/regional activity for functional imaging studies, as well as 
metabolic ratios of cerebral tissue compounds for MRS and binding potential of 
cerebral receptors for PET studies. There is the intracranial volume (ICV) as a sum of 
the volume of all voxels designated as gray matter volume, white matter volume plus 
cerebrospinal fluid and the whole brain volume (WBV) as a sum of gray matter plus 
white matter volume (Courchesne et al., 2000) recorded in the table 4. 
Results were comprehensively reported in different tables to assist the reader in 
forming an independent view on the following discussion. We have included one 
summary table of all reviewed studies (table 2), and tables illustrating the results of 
structural (table 3) and functional studies (table 5). 
 
2.3. Effect sizes 
 
When sufficient information was provided in a study to assess the significance of the 
results (e.g., presence of means and standard deviations, p value, F-value), we have 
calculated the effect size. The effect size is a dimensionless number that facilitates the 
integration of findings across the studies that used different types of measurements. It 
is related to the choice of whether or not greater reliance should be placed on studies 
carried out on larger samples. We have chosen an estimator corrected for the number 
of subjects included in each study using Cohen’s d statistic (Cohen, 1992), because a 
lot of fMRI or sMRI studies included small numbers of subjects. When the power of a 
study is insufficient to show statistically significant differences between or within 
samples or populations type II errors occur. The effect sizes better explain differences 
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in the population and whether these differences might merit further study. All 
calculated Cohen’s d values are based on baseline data from both cross-sectional and 
longitudinal studies. Effect size (indexed ‘d’ according to Cohen’s scheme (Cohen, 
1992)) means ‘the degree to which a phenomenon is present in the population (Cohen, 
1988). The value of Cohen‘s d stands for either negligible effect (>= -0.15 and <.15), 
small effect (>=.15 and <.40), medium effect (>=.40 and <.75), large effect (>=.75 
and <1.10), very large effect (>=1.10 and <1.45) or huge effect >1.45. Such 
methodological approach has been used in previous meta-analyses of neuroimaging 
studies (Fusar-Poli et al., 2007). 
 
2.4. Risk of bias in individual studies 
 
Publication bias reflects the increased likelihood of a study being published when the 
study has a positive result. Thus an intrinsic bias towards a positive result could be 
incorporated into the study, because fewer negative or equivocal studies exist in the 
literature (Callcut and Branson, 2009). We included three studies (Thompson et al., 
2007; Wood et al., 2005; Yucel et al., 2003) with negative results regarding the 
difference between HR-T and HR-NT. All our included studies were published in 
peer-reviewed journals suggesting high quality of published data and excluding the 
possible methodological bias. Although the studies differ methodologically, we did 
not found any difference in outcome-level assessment of risk of bias. 
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3. RESULTS 
 
3.1. Inclusion criteria for subjects at high-risk for psychosis  
  
Neuroimaging studies published in current literature included different high-risk 
samples: (a) genetic high-risk subjects (a1) monozygotic and dizygotic twins 
discordant for schizophrenia (non-psychotic twin) (a2) subjects with at least two first- 
or second-degree relatives of patients affected with psychosis (Hodges et al., 1999; 
Johnstone et al., 2000), (b) clinical high-risk subjects (b1) subjects at ultra high-risk 
(UHR) and (b2) with an at-risk mental state (ARMS) (Yung et al., 2004) (Riecher-
Rossler et al., 2007) (b3) subjects with ‘basic symptoms’ (e.g. thought and perception 
disturbances) (Klosterkotter et al., 2001). According to recent data, although the risks 
for psychosis and associated abnormalities are higher in high-risk samples than in the 
general population, they are not the same across these different groups: monozygotic 
twins have a 40–50% concordance rate for the illness over lifetime (Tsuang et al., 
2002), first-degree relatives of schizophrenia patients have approximately a 10-fold 
increased risk for later illness compared to non-relatives over lifetime (Chang et al., 
2002), while in clinical high-risk subjects the probability to develop psychosis ranges 
from 16% within 2 years (Yung et al., 2008) and 41% (ARMS) (Yung et al., 2003; 
Yung et al., 2007) up to 54% (Criteria for Prodromal Syndromes - COPS) (Miller et 
al., 2002) within one year (for review see (Cannon et al., 2007)), or 49% within 9,6 
years (Basic symptoms - Cologne Early Recognition (CER) Project) (Klosterkotter et 
al., 2001). 
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Finally, it is worth mentioning schizotypal personality disorder, which is 
characterized, like schizophrenia, by positive or psychotic-like symptoms and 
negative or deficit-like symptoms (Siever and Davis, 2004). Although the transition 
rate to psychosis in such groups is still under discussion (Bedwell and Donnelly, 
2005), schizotypy symptoms in subjects with a genetic risk for schizophrenia or in 
those with a functional decline (ARMS) are clearly associated with an increased risk 
for developing a psychotic episode (Siever et al., 2002).  
Selection criteria for clinical HR subjects are reported in table 1 according to the 
differences among the centers for early detection of psychosis. Two well established 
centers from the English-speaking area – Personal Assessment and Crisis Evaluation 
clinic (PACE) in Melbourne and Outreach And Support In South London clinic 
(OASIS) in London - have used the instrument called Comprehensive Assessment of 
Symptoms and History (CAARMS) (Yung et al., 2005) to assess the Attenuated 
psychotic symptoms (APS), Brief limited psychotic symptoms (BLIPS) and trait + 
state risk factor (Yung et al., 1998) in the high-risk population. The same criteria with 
the newly developed shorter Basel Screening Instrument for Psychosis (BSIP) 
(Riecher-Rossler et al., 2008; Riecher-Rossler et al., 2007) were assessed in Basel in 
the Early Detection of Psychosis Clinic (FEPSY). The German research network on 
schizophrenia (GRNS) in Bonn, Düsseldorf, Cologne and Munich working with the 
ERIRAOS (Maurer and Hafner, 2007) - Early Recognition Inventory based on 
Interview for the Retrospective Assessment of the Onset of Schizophrenia (IRAOS) 
(Hafner et al., 1992) and Bonn Scale for Assessment of Basic Symptoms (BSABS) 
(Klosterkotter et al., 2001) used the same criteria of Brief Psychiatric Rating Scale 
(BPRS) and Comprehensive Assessment of Symptoms and History (CASH).  
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TABLE 1 ABOUT HERE 
 
3.2. Number of identified studies  
 
As the approach of the selective comparison of HR-T versus HC, HR-NT and first 
episode (FE) patients is a relatively new one, all of the 30 studies initially identified, 
were published between 2002 and 2009. Three studies (Job et al., 2006; Koutsouleris 
et al., 2009a; McIntosh et al., 2007) were eliminated because they did not fulfil the a 
priori selection criteria (for included and excluded studies see Figure 1). The 
remaining studies were grouped according to centre/population of the study (clinical 
HR with an ARMS: Melbourne, Basel, Munich, Bonn; genetic HR: Edinburgh), 
neuroimaging technique employed (structural/functional), design of the study (cross-
sectional/longitudinal), and cognitive task (Figure 1, Table 2). The systematic review 
of the literature uncovered 20 structural imaging studies (16 MRI, two gyrification 
index (GI), two cortical pattern matching (CPM)) and five functional imaging studies 
(two fMRI, two Magnetic Resonance Spectroscopy (MRS) and one Positron Emission 
Tomography (PET)). The total number of subjects included in the present review 
encompassed roughly 385 HR subjects altogether, of whom 95 subsequently made a 
transition to psychosis (HR-T), 290 healthy controls (HC) and 211 first episode (FE) 
patients. The flowchart of the selection procedure with the included/excluded studies 
is summarized in Figure 1 and was created on the template of the PRISMA flow 
diagram (Minzenberg et al., 2009) available on the web site http://www.prisma-
statement.org/ . 
 
3.3. Risk of bias within studies 
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Within our included studies we have not found any differences in risk of bias. 
 
 
FIGURE 1 AND TABLE 2 ABOUT HERE 
 
The results of our systematic review and meta-analysis are summarized below with 
respect to structural (3.3) and functional (3.4.) imaging findings. 
 
3.4. Structural magnetic resonance imaging studies of individuals at high-risk of 
psychosis 
 
Two publications (Goghari et al., 2007; Witthaus et al., 2008) were excluded, because 
each of them comprised only one patient, who made the transition to psychosis. 
Across the selected imaging database we uncovered different structural neuroimaging 
methods: seven studies used voxel-based morphometry (VBM), nine studies used 
region of interest (ROI), two used studies gyrification index (GI) and further two used 
Cortical Pattern Matching (CPM). 
GI measures the ratio of the entire cortical (inner) contour of the brain to the 
superficially exposed or outer contour and increases proportionally with the number 
and complexity of gyri (Zilles et al., 1988). The group of Harris et al. have used hand-
traced GI methodology in an older study, and later an automated GI (A-GI) 
methodology of prefrontal cortex folding (Harris et al., 2007; Harris et al., 2004). 
CPM encodes both gyral patterning and gyral-matter variation (Thompson et al., 
2004). This is an advanced brain registration technique that can achieve accurate 
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anatomical correspondence between surfaces (Sun et al., 2009). One VBM study 
(Walterfang et al., 2008) determined whether changes in the gray matter are 
accompanied by changes in the white matter. 
 
TABLE 3 ABOUT HERE 
 
3.4.1. Structural magnetic resonance imaging studies using voxel-based methods  
 
3.4.1.1. Cross-sectional VBM studies of gray matter abnormalities  
 
The first VBM study examining gray matter volumes of HR-T versus HR-NT found 
less gray matter volume in right hippocampal, parahippocampal and cingulate cortex, 
lateral temporal and inferior frontal cortex at baseline (Pantelis et al., 2003).  
Studies by our own group showed that compared to HC, HR-T subjects had smaller 
gray matter volumes in the cingulate gyrus, precuneus and paracentral lobule 
bilaterally, the latter extending into the left superior parietal lobule (Borgwardt et al., 
2007a). At the same time there were regions with greater gray matter volume in right 
parahippocampal and supramarginal gyri and inferior temporal gyrus. These latter 
volumetric increases were evident already 1-2 years before transition to psychosis. 
When compared to HR-NT, HR-T subjects showed reduced gray matter volume in the 
superior temporal and inferior frontal gyrus and insula (Borgwardt et al., 2007b). 
Koutsouleris et al. (Koutsouleris et al., 2009b) also found frontal volumetric 
reductions predominantly in the anterior cingulate, prefrontal and orbitofrontal cortex 
bilaterally in HR-T subjects compared to the HR-NT patients.  
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Cross-sectional VBM studies thus found identically decreased gray matter volume in 
frontal, cingulate and temporal cortex in HR-T compared to HR-NT.  
 
3.4.1.2. Longitudinal VBM studies of gray matter abnormalities  
 
Other studies focused on the longitudinal changes underlying the onset of psychosis. 
In a subgroup of already mentioned sample Pantelis et al. studied also progressive 
changes and found gray matter reductions in the left hemisphere in medial temporal, 
orbitofrontal, cingulate cortex and cerebellum (Pantelis et al., 2003). 
Borgwardt et al. (Borgwardt et al., 2008) reported orbitofrontal, superior frontal, 
inferior temporal, medial and superior parietal cortex and cerebellar gray matter 
reductions in HR-T patients compared to HR-NT. 
The only genetic high-risk longitudinal study (Job et al., 2005) found lower gray 
matter density in left inferior temporal gyrus, uncus and right cerebellum over follow-
up between HR-T and HR-NT subjects (Job et al., 2005). 
The greater brain surface contraction in the right prefrontal region was another 
progressive change seen in HR-T compared HR-NT (Sun et al., 2009). Takahashi and 
colleagues found longitudinal gray matter volume reduction in superior temporal 
gyrus left in HR-T compared to HR-NT (Takahashi et al., 2009b). 
The most consistent results of progressive studies with HR-T versus HR-NT 
comparison included temporal, frontal and cerebellar gray matter reduction.  
 
3.4.1.3. VBM studies comparing FE and HR-T 
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The differences in gray matter volumes between FE schizophrenia patients and HR-T 
were evaluated only in three studies (Borgwardt et al., 2007a; Phillips et al., 2002; 
Takahashi et al., 2009b). Cross-sectional comparisons showed volume reductions in 
the superior temporal gyrus in FE subjects as compared to HR-T, HR-NT and HC. 
Both FE and HR-T showed progressive reduced gray matter volume in superior 
temporal regions (Takahashi et al., 2009b).  
According to a study by our own group, there were gray matter volume reductions in 
FE as compared to HR-T along the superior, middle and inferior temporal gyrus and 
the region of larger gray matter volume in the right lentiform nucleus (Borgwardt et 
al., 2007a). 
 
3.4.1.4. Other studies  
 
Walterfang et al (Walterfang et al., 2008) focused on white matter abnormalities in 
HR population using VBM. They found that compared to HR-NT, HR-T subjects 
showed larger white matter volumes in the left frontal lobe. Longitudinally, HR-T 
revealed a reduction in white matter volume in a region of the left fronto-occipital 
fasciculus (Walterfang et al., 2008). 
Harris and colleagues measured the hand-traced gyrification index and found 
increases in right prefrontal lobe GI values in HR-T individuals compared to HR-NT 
(Harris et al., 2004). Interestingly, the disproportionately high right prefrontal GI 
distinguishes the HR-T from other groups (HR-NT, HC, FE) and can predict 
schizophrenia several years before, while white matter volume can not (Harris et al., 
2007). 
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3.4.2. Structural magnetic resonance imaging studies using region-of-interest (ROI) 
approaches  
 
ROI approaches have also been used in a number of brain morphology studies of the 
HR population. They often used various procedures to describe the brain areas, which 
are either manually or automatically delineated. Despite of this we discuss the results 
from ROI studies according to the investigated regions. 
 
Medial temporal region 
 
Here we present findings related to hippocampal and amygdala volumes as a part of 
the medial temporal lobe (Shenton et al., 2001). Volumetric hippocampal 
measurements were provided in five MRI studies. An early cross-sectional study by 
Phillips et al. (Phillips et al., 2002) reported smaller hippocampal volumes in HR-T 
compared to HR-NT. Similar results have been observed in FE patients compared to 
HR-T while no differences were found between HR-T and HC (Phillips et al., 2002). 
In contrast, two larger studies (Velakoulis et al., 2006; Wood et al., 2005) reported no 
differences in hippocampal volume between HR-T and HR-NT. Bühlmann et al. 
(Buehlmann et al., 2009) also failed to find volumetric differences in the hippocampus 
in HR-T vs. HR-NT albeit in a smaller sample. No relationship between cortisol 
plasma levels and hippocampal volumes was observed in the neurobiological model 
of stress in cross-sectional study by Thompson et al. (Thompson et al., 2007). 
Another cross-sectional study showed no differences in amygdala volume among HR-
T and HR-NT, HC and FE patients (Velakoulis et al., 2006). 
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Cingulate cortex 
 
The anterior cingulate cortex (ACC) was investigated in three studies from the 
Melbourne group (Fornito et al., 2008; Wood et al., 2005; Yucel et al., 2003). Yücel 
(Yucel et al., 2003) found no differences in any of the ACC surface morphological 
measures between HR-T and HR-NT. Another study showed a trend towards left 
hemispheric reduced paracingulate sulcus folding and frequent cingulate sulcus 
interruptions in HR subjects, with no differences between HR-T and HR-NT subjects, 
in line with the above findings (Wood et al., 2005).  
Fornito (Fornito et al., 2008) used a surface-based anterior cingulate parcelation 
technique and reported that regional thinning of the ACC is a significant predictor of 
the time to psychosis onset. They found a bilateral thinning of the rostral paralimbic 
ACC in HR-T compared to HC. 
 
Insular cortex 
 
We uncovered VBM studies (Borgwardt et al., 2007b; Pantelis et al., 2003) showing 
insular gray matter reductions in the HR-T compared to the HR-NT. These findings 
were parallel to the cross sectional and longitudinal insular gray matter abnormalities 
observed within the HR group (Takahashi et al., 2009a). 
 
Pituitary 
 
Garner (Garner et al., 2005) reported that within the HR subjects the baseline pituitary 
volume was a significant predictor of future transition to psychosis. HR-T subjects 
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had significantly larger pituitary volumes than HC. At the same time HC had larger 
pituitary volume than HR-NT. Thompson et al. found no relationship between cortisol 
plasma levels or number of glucocorticoid receptors and pituitary volume, suggesting 
that impairment in hypothalamic-pituitary-adrenal axis may be detectable later in the 
disease process (Thompson et al., 2007). 
 
3.4.3. Meta-Analysis of structural magnetic resonance imaging studies 
 
We have calculated Cohen`s d in 11 of 20 included sMRI studies (Table 4). The study 
by Walterfang et al. (Walterfang et al., 2008) was excluded as it focuses on the white 
matter changes. Three studies without control group (Pantelis et al., 2003; Sun et al., 
2009; Thompson et al., 2007) have considerably influenced the direction of 
subsequent research and were included, albeit we could not calculate Cohen`s d. 
Effect size was not calculated in another two studies with no significant differences 
between HR-T and HR-NT (Wood et al., 2005; Yucel et al., 2003) and in two another 
studies (Borgwardt et al., 2008; Job et al., 2005) as well. 
With small to medium effect sizes, whole brain volumes and/or global gray matter 
volumes were consistently increased in HR-T relative to HR-NT but also compared to 
FE patients (Borgwardt et al., 2007a; Borgwardt et al., 2007b; Harris et al., 2007; 
Harris et al., 2004; Takahashi et al., 2009a; Takahashi et al., 2009b; Velakoulis et al., 
2006). This increase is also seen in comparison of HR-T to the HC with medium 
effect size with the exception of one study reporting a small effect size of decrease of 
gray matter volume in HR-T compared to HC (Borgwardt et al., 2007b) (table 4).  
Compared to HR-NT, HR-T subjects showed relatively reduced regional gray matter 
volume in the insula (Borgwardt et al., 2007b; Pantelis et al., 2003; Takahashi et al., 
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2009a), anterior cingulate (Fornito et al., 2008; Pantelis et al., 2003), prefrontal cortex 
(Borgwardt et al., 2008; Pantelis et al., 2003; Sun et al., 2009) and cerebellum 
(Borgwardt et al., 2008; Job et al., 2005; Pantelis et al., 2003) with small to large 
effect sizes (table 4). These regions were the most consistently abnormal brain regions 
associated with later transition to psychosis. Through that two ROI-studies found no 
differences in anterior cingulate among HR individuals (Wood et al., 2005; Yucel et 
al., 2003) and one study found increased gray matter volume in right prefrontal cortex 
in HR-T compared to HR-NT (Harris et al., 2004). 
 
TABLE 4 ABOUT HERE 
 
3.5. Functional neuroimaging and neurochemical studies of individuals at high-risk 
for psychosis 
 
We uncovered a few functional neuroimaging studies employing different imaging 
methods.  
The Edinburgh group employed the Hayling Sentence Completion Task (HSCT) and 
the ‘Theory of Mind’ paradigm (Marjoram et al., 2006; Whalley et al., 2006). One 
positron emission tomography (PET) study (Hurlemann et al., 2008) had focused on 
the availability of the cerebral serotonin (5-HT) receptor in naive HR subjects. 
Finally, two proton magnetic resonance spectroscopy (MRS) studies (Jessen et al., 
2006; Wood et al., 2003) measured N-acetyl aspartat (NAA), cholin (Cho) and 
creatine (Cr) as marker for neuronal density, function and cell metabolism 
respectively. 
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TABLE 5 ABOUT HERE 
 
3.5.1. Functional MRI (fMRI) studies 
 
Both studies from this subsection have investigated cross-sectional abnormalities 
between HR-T and HR-NT subjects. 
Decreased activation in anterior cingulate cortex and increased activation in left 
parietal lobe were described in genetic HR-T relative to HC in a prospective cross-
sectional study using the HSCT (Whalley et al., 2006). Compared to HR-NT, HR-T 
subjects showed smaller increases in activation with increasing task difficulty in the 
right lingual gyrus (Whalley et al., 2006). In a ‘Theory of Mind’ imaging study, which 
requires ability to understand a joke, Marjoram et al. (Marjoram et al., 2006) 
investigated prefrontal cortex activation associated with memory and executive 
functioning tasks. Compared to HR-NT, HR-T showed less neural activation in the 
middle frontal gyrus right (Marjoram et al., 2006).  
 
3.5.2. Other functional neuroimaging studies (PET, MRS) 
 
Hurlemann et al. investigated abnormalities in serotonin subtype 2A receptor (5-
HT2AR) in prefrontal cortex using PET. 5-HT2AR binding potential (BP) in right 
caudate nucleus was significantly reduced in HR-T compared to HC. Furthermore, 
HR-T compared to HR-NT had the most significant decreases in 5-HT2AR BP in the 
insular cortex (Hurlemann et al., 2008).  
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Using MRS, the HR-T subjects showed reduced NAA/Cho ration as compared to HR-
NT, suggesting an impaired neuronal density and function. Jessen et al. (Jessen et al., 
2006) showed a significantly lower NAA/Cho and higher Cho/Cr in HR-T compared 
to HR-NT in the anterior cingulate gyrus and a trend towards a reduction of NAA/Cho 
in the frontal lobe. Reductions of NAA in the left prefrontal lobe and ACC may 
represent a vulnerability to schizophrenia and elevated levels of cholin containing 
compounds in the anterior cingulate gyrus may predict conversion to frank psychosis 
(Jessen et al., 2006). 
In a second MRS study, Wood et al. (Wood et al., 2003) investigated medial temporal 
and dorsolateral prefrontal regions but found no significant differences in NAA, Cr 
and Cho levels within the HR sample (HR-T vs HR-NT). However, there was a trend 
toward a significantly higher NAA/Cho in the HR-T compared to HR-NT in the 
medial temporal region (Wood et al., 2003). 
 
3.5.3. Meta-Analysis of functional imaging studies 
 
Cohen`s d calculated from functional imaging data showed altered activation of the 
brain regions (table 6), where gray and white matter changes were observed (table 4), 
but in other brain regions as well. 
fMRI studies have found less activation in HR-T compared to HR-NT in prefrontal 
cortex with medium effect size (Marjoram et al., 2006), and in cingulate cortex and in 
occipital lobe (Whalley et al., 2006). 
Conversely, MRS studies showed a huge effect size of the reduction of neuronal 
density and increased membrane turnover in cingulate (Jessen et al., 2006). They also 
proved an increase of neuronal density in medial temporal cortex (Wood et al., 2003) 
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in HR-T compared to HR-NT. The availability of 5-HT2A receptors was significantly 
decreased as we found a huge effect size in HR-T compared to HR-NT in prefrontal 
cortex (Hurlemann et al., 2008). 
 
TABLE 6 ABOUT HERE 
 
4. DISCUSSION 
 
With this study we aimed at reviewing the neuroimaging predictors of transition to 
psychosis. We were searching neuroanatomical and neurofunctional abnormalities of 
HR-T in relation to HR-NT, HC and FE. According to our first hypothesis, structural 
neuroimaging studies revealed volumetric abnormalities in temporal, cingulate, 
insular, prefrontal cortex and in cerebellum in HRT already before transition to 
psychosis compared to HR-NT. The present meta-analysis showed small to medium 
effect size of increased whole brain volume and total gray matter volume in the group 
of the HR-T as compared to the HR-NT, but interestingly also compared to the FE 
and to the HC. This effect of increased whole brain volume could indicate a dynamic 
process during the transition phase to psychosis, presumably affecting various cortical 
areas at approximately identical time points.  
Functional neuroimaging studies showed reduced brain activation in prefrontal cortex, 
reduced neuronal density, increased membrane turnover in frontal and cingulate 
cortex and decreased availability of serotonine receptors in prefrontal cortex with 
medium to large effect sizes. The localization of neurofunctional abnormalities 
between HR-T and HR-NT corresponds to the region-specific neuroanatomical 
abnormalities revealed by structural neuroimaging studies. These neurofunctional 
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abnormalities could delineate a pathological process in the affected brain regions as 
well as a compensatory process to volumetric region-specific reductions in gray or 
white matter.  
 
4.1. Brain structural and neurofunctional abnormalities associated with transition to 
psychosis 
 
This review and meta-analysis shows that the transition from a prodromal state to the 
onset of psychosis (as compared between HR-T and HR-NT) is associated with 
patterns of subtle gray matter abnormalities within frontal and temporal cortices, the 
limbic system and the cerebellum (Borgwardt et al., 2007b; Job et al., 2003; 
Meisenzahl et al., 2008; Pantelis et al., 2003). 
 
Our review added evidence to the available literature by showing that structural 
abnormalities in medial temporal, prefrontal, anterior cingulate and insular cortex 
might be most predictive for a development of psychosis. At least some of the cortical 
gray matter abnormalities known in psychotic patients seem to occur during the acute 
process of transition to psychosis. While some subtle alterations in brain structure 
(reductions in cingulate, insular and prefrontal regions) (Borgwardt et al., 2007b; 
Koutsouleris et al., 2009b; Pantelis et al., 2003) seem to occur already in the 
prodromal stage, other brain structural changes (i.e. superior temporal gyrus volume 
reductions) (Takahashi et al., 2009b) found in psychoses may emerge as psychosis 
develops.  
Although fMRI did not reveal significant effect sizes, the present findings of 
decreased activation in prefrontal areas and increased activation in connected brain 
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regions could indicate a compensatory mechanism. Contemporary meta-analysis of 41 
executive fMRI studies of schizophrenia patients showed reduced activation in a 
similar neural network in prefrontal cortex, and anterior cingulate as in healthy 
controls, and compensatory increased activation in other prefrontal areas (Minzenberg 
et al., 2009).  
MRS and PET studies have shown a huge effect size of the reduction of neuronal 
density and increased membrane turnover in frontal lobe and cingulate as well as 
decreased availability of serotonine receptors in prefrontal cortex in HR-T compared 
to HR-NT.  
Although we have found structural gray matter alterations and neuronal activity 
reduction in prefrontal and cingulate cortex and reduction in neuronal activity in 
occipital lobe in HR-T versus HR-NT, it is difficult to describe their relationship. 
Similarly, the reductions in white matter volume in the left fronto-occipital fasciculus 
(Walterfang et al., 2008) were found hand in hand with the reduction in gray matter 
volume in orbito-frontal, cingulate and parahippocampal areas (Pantelis et al., 2003) 
longitudinally in identical HR-T versus HR-NT population. 
 
These observations are of great relevance and may be useful in filling the gap between 
basic and clinical neuroscience. In fact, the researchers have attempted to find reliable 
MRI-based correlates of prediction to the psychosis combining longitudinal changes 
in gray matter alterations with other clinical and cognitive predictive measures (Job et 
al., 2006). A recently published study (Koutsouleris et al., 2009a) has distinguished 
HR subjects from HC as well HR-T from HR-NT by using advanced analysis 
methods such as the support vector machines (SMVs). They have achieved fairly high 
accuracy, sensitivity and specificity in their prediction to psychosis based on the 
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pattern of gray matter volume reductions in temporal and prefrontal cortex, in the 
thalamus and the cerebellum in HR-T versus HR-NT.  
Neuroimaging may be able to decompose state and trait variables during the early 
phases of psychosis. Structural and functional neuroimaging (and the combination of 
imaging techniques) have the potential to delineate the time course of brain 
abnormalities in the evolution of psychosis. The observation that transition to 
psychosis is associated with specific structural and neurofunctional abnormalities 
raises the possibility that multimodal neuroimaging techniques could be used to 
identify the core pathophysiological changes underlying the onset of psychosis 
(Fusar-Poli et al., 2009).  
 
4.2. Methodological issues and limit of this study 
 
Limits of the present review and meta-analysis are well acknowledged. The methods 
and extent of detailed information to define regions of interest vary widely between 
the studies, preventing accurate comparison. In addition we uncovered a large 
difference in secondary variables across studies (i.e. gender, medication, 
comorbidities), which may have played a confounding role. In particular, the 
relatively small number of fMRI findings may be secondary to the limited number of 
available fMRI studies or to heterogeneity across paradigms employed (Fusar-Poli et 
al., 2008). 
 
Additionally, we could not address the question how consistent brain changes are at 
specific times in particular anatomical regions. Overall, neuroimaging studies of 
people who later develop psychosis comprised small samples and might therefore not 
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be representative. Some studies used standard VBM, while others used an ‘optimized’ 
VBM method (Good et al., 2001). However, the use of VBM or optimized VBM 
method implicates compatibility problems (Ashburner and Friston, 2000). The size of 
the smoothing kernel is also relevant, because it should be roughly the size of the 
expected findings. In addition, gray matter reductions may also reflect a variety of 
neuropathological changes, e.g. exaggerated dendritic or synaptic pruning 
(McGlashan and Hoffman, 2000)), impaired myelination (Bartzokis et al., 2003), 
apoptosis (Glantz et al., 2006), or neurotoxic effects of antipsychotic medications 
(Reinke et al., 2004). Furthermore, differences in scanning parameters, image analysis 
and packages may account for inconsistencies in neuroimaging measures (Fusar-Poli 
et al., 2008).  
 
Together with the concept of early detection of psychosis, the time point of 
therapeutic intervention was pushed back before the onset of frank psychosis 
(McGorry et al., 2009). A clinical staging model suggests safer, more benign 
intervention in early high-risk state and could help to design randomised control trials 
without confounders such as antipsychotic medication. Although brain structural and 
functional abnormalities were evident in antipsychotic-naïve HR subjects (Hurlemann 
et al., 2008; Job et al., 2005; Koutsouleris et al., 2009b; Pantelis et al., 2003; 
Thompson et al., 2007; Whalley et al., 2006), antipsychotic medication may also 
contribute to progressive brain structural and functional alterations observed in studies 
including HR subjects after they have developed psychosis (Smieskova et al., 2009). 
It is an intrinsic difficulty in longitudinal studies of HR subjects, as once a subject has 
developed frank psychosis, immediate treatment with antipsychotic medication is 
indicated. An alternative approach is to conduct follow up scanning before the onset 
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of psychosis, while subjects are usually antipsychotic-naïve. This may reveal 
longitudinal changes that predate the onset of illness and that are not confounded by 
the effects of antipsychotic medication. Overall, longitudinal imaging studies may 
have the advantage of powerful, within-subject designs, while multi-site studies may 
overcome the problem of small sample sizes and bridge basic neuroscience with 
clinical psychiatry. 
 
5. CONCLUSIONS 
 
Despite a wide range of methodological differences between studies, structural and 
neurochemical abnormalities in prefrontal, anterior cingulate and medial temporal 
cortex might be predictive for a development of psychosis. Neuroimaging studies of 
high-risk patients who later develop psychosis may in future lead to neuroanatomical 
and neurofunctional markers. These markers could be initially used in a multi-domain 
early detection approach and at a later stage enable the prediction of disease transition 
at an individual level. Although clinical relevance of brain abnormalities in this group 
is not completely established yet, neuroimaging studies in prodromal putative subjects 
could provide the targets for early intervention that could potentially prevent a chronic 
clinical trajectory of the illness. 
 
Acknowledgements 
 
This study was supported by grants from the Swiss National Science Foundation 
(Project No. 3232BO_119382). 
 30
 
References 
 
Ashburner, J., Friston, K.J., 2000. Voxel-based morphometry--the methods. 
Neuroimage 11, 805-821. 
Baare, W.F., van Oel, C.J., Hulshoff Pol, H.E., Schnack, H.G., Durston, S., Sitskoorn, 
M.M., Kahn, R.S., 2001. Volumes of brain structures in twins discordant for 
schizophrenia. Arch Gen Psychiatry 58, 33-40. 
Bartzokis, G., Nuechterlein, K.H., Lu, P.H., Gitlin, M., Rogers, S., Mintz, J., 2003. 
Dysregulated brain development in adult men with schizophrenia: a magnetic 
resonance imaging study. Biol Psychiatry 53, 412-421. 
Bedwell, J.S., Donnelly, R.S., 2005. Schizotypal personality disorder or prodromal 
symptoms of schizophrenia? Schizophr Res 80, 263-269. 
Borgwardt, S.J., McGuire, P.K., Aston, J., Berger, G., Dazzan, P., Gschwandtner, U., 
Pfluger, M., D'Souza, M., Radue, E.W., Riecher-Rossler, A., 2007a. Structural brain 
abnormalities in individuals with an at-risk mental state who later develop psychosis. 
Br J Psychiatry Suppl 51, s69-75. 
Borgwardt, S.J., McGuire, P.K., Aston, J., Gschwandtner, U., Pfluger, M.O., Stieglitz, 
R.D., Radue, E.W., Riecher-Rossler, A., 2008. Reductions in frontal, temporal and 
parietal volume associated with the onset of psychosis. Schizophr Res 106, 108-114. 
Borgwardt, S.J., Riecher-Rossler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M., 
Gschwandtner, U., Haller, S., Pfluger, M., Rechsteiner, E., D'Souza, M., Stieglitz, 
R.D., Radu, E.W., McGuire, P.K., 2007b. Regional gray matter volume abnormalities 
in the at risk mental state. Biol Psychiatry 61, 1148-1156. 
Brewer, W.J., Wood, S.J., Phillips, L.J., Francey, S.M., Pantelis, C., Yung, A.R., 
Cornblatt, B., McGorry, P.D., 2006. Generalized and specific cognitive performance 
 31
in clinical high-risk cohorts: a review highlighting potential vulnerability markers for 
psychosis. Schizophr Bull 32, 538-555. 
Buehlmann, E., Berger, G.E., Aston, J., Gschwandtner, U., Pflueger, M., Borgwardt, 
S.J., Radue, E.W., Riecher-Rössler, A., 2009. No Hippocampus abnormalities in at 
risk mental state, but in first episode psychosis. A cross-sectional high resolution 
region of interest magnetic resonance imaging study. Journal of Psychiatric Research. 
Callcut, R.A., Branson, R.D., 2009. How to read a review paper. Respir Care 54, 
1379-1385. 
Cannon, T.D., 2005. Clinical and genetic high-risk strategies in understanding 
vulnerability to psychosis. Schizophr Res 79, 35-44. 
Cannon, T.D., Cornblatt, B., McGorry, P., 2007. The empirical status of the ultra 
high-risk (prodromal) research paradigm. Schizophr Bull 33, 661-664. 
Chang, C.J., Chen, W.J., Liu, S.K., Cheng, J.J., Yang, W.C., Chang, H.J., Lane, H.Y., 
Lin, S.K., Yang, T.W., Hwu, H.G., 2002. Morbidity risk of psychiatric disorders 
among the first degree relatives of schizophrenia patients in Taiwan. Schizophr Bull 
28, 379-392. 
Cohen, J., 1988. Statistical power analysis for the behavioural sciences, 2nd ed. 
Lawrence Erlbaum Associates, Hillsdale, NJ. 
Cohen, J., 1992. A power primer. Psychol Bull 112, 155-159. 
Cornblatt, B., Lencz, T., Obuchowski, M., 2002. The schizophrenia prodrome: 
treatment and high-risk perspectives. Schizophr Res 54, 177-186. 
Courchesne, E., Chisum, H.J., Townsend, J., Cowles, A., Covington, J., Egaas, B., 
Harwood, M., Hinds, S., Press, G.A., 2000. Normal brain development and aging: 
quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 216, 
672-682. 
 32
DeLisi, L.E., 2008. The concept of progressive brain change in schizophrenia: 
implications for understanding schizophrenia. Schizophr Bull 34, 312-321. 
DeLisi, L.E., Sakuma, M., Tew, W., Kushner, M., Hoff, A.L., Grimson, R., 1997. 
Schizophrenia as a chronic active brain process: a study of progressive brain structural 
change subsequent to the onset of schizophrenia. Psychiatry Res 74, 129-140. 
Fornito, A., Yung, A.R., Wood, S.J., Phillips, L.J., Nelson, B., Cotton, S., Velakoulis, 
D., McGorry, P.D., Pantelis, C., Yucel, M., 2008. Anatomic abnormalities of the 
anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk 
individuals. Biol Psychiatry 64, 758-765. 
Fusar-Poli, P., Allen, P., McGuire, P., 2008. Neuroimaging studies of the early stages 
of psychosis: a critical review. Eur Psychiatry 23, 237-244. 
Fusar-Poli, P., Howes, O., Valli, I., Allen, P., Broome, M., Grasby, P., McGuire, P., 
2009. Multimodal functional imaging investigation before and after the onset of 
psychosis. Int J Neuropsychopharmacol 12, 579-581. 
Fusar-Poli, P., Perez, J., Broome, M., Borgwardt, S., Placentino, A., Caverzasi, E., 
Cortesi, M., Veggiotti, P., Politi, P., Barale, F., McGuire, P., 2007. Neurofunctional 
correlates of vulnerability to psychosis: a systematic review and meta-analysis. 
Neurosci Biobehav Rev 31, 465-484. 
Garner, B., Pariante, C.M., Wood, S.J., Velakoulis, D., Phillips, L., Soulsby, B., 
Brewer, W.J., Smith, D.J., Dazzan, P., Berger, G.E., Yung, A.R., van den Buuse, M., 
Murray, R., McGorry, P.D., Pantelis, C., 2005. Pituitary volume predicts future 
transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol 
Psychiatry 58, 417-423. 
Glahn, D.C., Laird, A.R., Ellison-Wright, I., Thelen, S.M., Robinson, J.L., Lancaster, 
J.L., Bullmore, E., Fox, P.T., 2008. Meta-analysis of gray matter anomalies in 
 33
schizophrenia: application of anatomic likelihood estimation and network analysis. 
Biol Psychiatry 64, 774-781. 
Glantz, L.A., Gilmore, J.H., Lieberman, J.A., Jarskog, L.F., 2006. Apoptotic 
mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 81, 47-63. 
Goghari, V.M., Rehm, K., Carter, C.S., MacDonald, A.W., 3rd, 2007. Regionally 
specific cortical thinning and gray matter abnormalities in the healthy relatives of 
schizophrenia patients. Cereb Cortex 17, 415-424. 
Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J., Frackowiak, 
R.S., 2001. A voxel-based morphometric study of ageing in 465 normal adult human 
brains. Neuroimage 14, 21-36. 
Hafner, H., Riecher-Rossler, A., Hambrecht, M., Maurer, K., Meissner, S., 
Schmidtke, A., Fatkenheuer, B., Loffler, W., van der Heiden, W., 1992. IRAOS: an 
instrument for the assessment of onset and early course of schizophrenia. Schizophr 
Res 6, 209-223. 
Harris, J.M., Moorhead, T.W., Miller, P., McIntosh, A.M., Bonnici, H.M., Owens, 
D.G., Johnstone, E.C., Lawrie, S.M., 2007. Increased prefrontal gyrification in a large 
high-risk cohort characterizes those who develop schizophrenia and reflects abnormal 
prefrontal development. Biol Psychiatry 62, 722-729. 
Harris, J.M., Whalley, H., Yates, S., Miller, P., Johnstone, E.C., Lawrie, S.M., 2004. 
Abnormal cortical folding in high-risk individuals: a predictor of the development of 
schizophrenia? Biol Psychiatry 56, 182-189. 
Ho, B.C., Andreasen, N.C., Nopoulos, P., Arndt, S., Magnotta, V., Flaum, M., 2003. 
Progressive structural brain abnormalities and their relationship to clinical outcome: a 
longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen 
Psychiatry 60, 585-594. 
 34
Hodges, A., Byrne, M., Grant, E., Johnstone, E., 1999. People at risk of 
schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-
Risk Study. Br J Psychiatry 174, 547-553. 
Honea, R., Crow, T.J., Passingham, D., Mackay, C.E., 2005. Regional deficits in 
brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. 
Am J Psychiatry 162, 2233-2245. 
Hulshoff Pol, H.E., Brans, R.G., van Haren, N.E., Schnack, H.G., Langen, M., Baare, 
W.F., van Oel, C.J., Kahn, R.S., 2004. Gray and white matter volume abnormalities in 
monozygotic and same-gender dizygotic twins discordant for schizophrenia. Biol 
Psychiatry 55, 126-130. 
Hurlemann, R., Matusch, A., Kuhn, K.U., Berning, J., Elmenhorst, D., Winz, O., 
Kolsch, H., Zilles, K., Wagner, M., Maier, W., Bauer, A., 2008. 5-HT2A receptor 
density is decreased in the at-risk mental state. Psychopharmacology (Berl) 195, 579-
590. 
Jessen, F., Scherk, H., Traber, F., Theyson, S., Berning, J., Tepest, R., Falkai, P., 
Schild, H.H., Maier, W., Wagner, M., Block, W., 2006. Proton magnetic resonance 
spectroscopy in subjects at risk for schizophrenia. Schizophr Res 87, 81-88. 
Job, D.E., Whalley, H.C., Johnstone, E.C., Lawrie, S.M., 2005. Grey matter changes 
over time in high risk subjects developing schizophrenia. Neuroimage 25, 1023-1030. 
Job, D.E., Whalley, H.C., McConnell, S., Glabus, M., Johnstone, E.C., Lawrie, S.M., 
2003. Voxel-based morphometry of grey matter densities in subjects at high risk of 
schizophrenia. Schizophr Res 64, 1-13. 
Job, D.E., Whalley, H.C., McIntosh, A.M., Owens, D.G., Johnstone, E.C., Lawrie, 
S.M., 2006. Grey matter changes can improve the prediction of schizophrenia in 
subjects at high risk. BMC Med 4, 29. 
 35
Johnson, J.K., Tuulio-Henriksson, A., Pirkola, T., Huttunen, M.O., Lonnqvist, J., 
Kaprio, J., Cannon, T.D., 2003. Do schizotypal symptoms mediate the relationship 
between genetic risk for schizophrenia and impaired neuropsychological performance 
in co-twins of schizophrenic patients? Biol Psychiatry 54, 1200-1204. 
Johnstone, E.C., Abukmeil, S.S., Byrne, M., Clafferty, R., Grant, E., Hodges, A., 
Lawrie, S.M., Owens, D.G., 2000. Edinburgh high risk study--findings after four 
years: demographic, attainment and psychopathological issues. Schizophr Res 46, 1-
15. 
Kasai, K., Shenton, M.E., Salisbury, D.F., Hirayasu, Y., Lee, C.U., Ciszewski, A.A., 
Yurgelun-Todd, D., Kikinis, R., Jolesz, F.A., McCarley, R.W., 2003. Progressive 
decrease of left superior temporal gyrus gray matter volume in patients with first-
episode schizophrenia. Am J Psychiatry 160, 156-164. 
Klosterkotter, J., Hellmich, M., Steinmeyer, E.M., Schultze-Lutter, F., 2001. 
Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58, 
158-164. 
Koutsouleris, N., Meisenzahl, E.M., Davatzikos, C., Bottlender, R., Frodl, T., 
Scheuerecker, J., Schmitt, G., Zetzsche, T., Decker, P., Reiser, M., Moller, H.J., 
Gaser, C., 2009a. Use of neuroanatomical pattern classification to identify subjects in 
at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 
66, 700-712. 
Koutsouleris, N., Schmitt, G.J., Gaser, C., Bottlender, R., Scheuerecker, J., McGuire, 
P., Burgermeister, B., Born, C., Reiser, M., Moller, H.J., Meisenzahl, E.M., 2009b. 
Neuroanatomical correlates of different vulnerability states for psychosis and their 
clinical outcomes. Br J Psychiatry 195, 218-226. 
 36
Lawrie, S.M., McIntosh, A.M., Hall, J., Owens, D.G., Johnstone, E.C., 2008. Brain 
structure and function changes during the development of schizophrenia: the evidence 
from studies of subjects at increased genetic risk. Schizophr Bull 34, 330-340. 
Lawrie, S.M., Whalley, H., Kestelman, J.N., Abukmeil, S.S., Byrne, M., Hodges, A., 
Rimmington, J.E., Best, J.J., Owens, D.G., Johnstone, E.C., 1999. Magnetic 
resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 
353, 30-33. 
Lawrie, S.M., Whalley, H.C., Abukmeil, S.S., Kestelman, J.N., Miller, P., Best, J.J., 
Owens, D.G., Johnstone, E.C., 2002. Temporal lobe volume changes in people at high 
risk of schizophrenia with psychotic symptoms. Br J Psychiatry 181, 138-143. 
Lencz, T., Smith, C.W., Auther, A., Correll, C.U., Cornblatt, B., 2004. Nonspecific 
and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. 
Schizophr Res 68, 37-48. 
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., Bilder, R., 
2001. Longitudinal study of brain morphology in first episode schizophrenia. Biol 
Psychiatry 49, 487-499. 
Marjoram, D., Job, D.E., Whalley, H.C., Gountouna, V.E., McIntosh, A.M., 
Simonotto, E., Cunningham-Owens, D., Johnstone, E.C., Lawrie, S., 2006. A visual 
joke fMRI investigation into Theory of Mind and enhanced risk of schizophrenia. 
Neuroimage 31, 1850-1858. 
Maurer, K., Hafner, H., 2007. [Early diagnosis of schizophrenia]. MMW Fortschr 
Med 149, 36-38. 
McGlashan, T.H., Hoffman, R.E., 2000. Schizophrenia as a disorder of 
developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57, 637-648. 
 37
McGlashan, T.H., Johannessen, J.O., 1996. Early detection and intervention with 
schizophrenia: rationale. Schizophr Bull 22, 201-222. 
McGorry, P.D., Nelson, B., Amminger, G.P., Bechdolf, A., Francey, S.M., Berger, 
G., Riecher-Rossler, A., Klosterkotter, J., Ruhrmann, S., Schultze-Lutter, F., 
Nordentoft, M., Hickie, I., McGuire, P., Berk, M., Chen, E.Y., Keshavan, M.S., Yung, 
A.R., 2009. Intervention in individuals at ultra high risk for psychosis: a review and 
future directions. J Clin Psychiatry. 
McIntosh, A.M., Baig, B.J., Hall, J., Job, D., Whalley, H.C., Lymer, G.K., Moorhead, 
T.W., Owens, D.G., Miller, P., Porteous, D., Lawrie, S.M., Johnstone, E.C., 2007. 
Relationship of catechol-O-methyltransferase variants to brain structure and function 
in a population at high risk of psychosis. Biol Psychiatry 61, 1127-1134. 
Meisenzahl, E.M., Koutsouleris, N., Gaser, C., Bottlender, R., Schmitt, G.J., 
McGuire, P., Decker, P., Burgermeister, B., Born, C., Reiser, M., Moller, H.J., 2008. 
Structural brain alterations in subjects at high-risk of psychosis: a voxel-based 
morphometric study. Schizophr Res 102, 150-162. 
Miller, T.J., McGlashan, T.H., Rosen, J.L., Somjee, L., Markovich, P.J., Stein, K., 
Woods, S.W., 2002. Prospective diagnosis of the initial prodrome for schizophrenia 
based on the Structured Interview for Prodromal Syndromes: preliminary evidence of 
interrater reliability and predictive validity. Am J Psychiatry 159, 863-865. 
Minzenberg, M.J., Laird, A.R., Thelen, S., Carter, C.S., Glahn, D.C., 2009. Meta-
analysis of 41 functional neuroimaging studies of executive function in schizophrenia. 
Arch Gen Psychiatry 66, 811-822. 
Morey, R.A., Inan, S., Mitchell, T.V., Perkins, D.O., Lieberman, J.A., Belger, A., 
2005. Imaging frontostriatal function in ultra-high-risk, early, and chronic 
schizophrenia during executive processing. Arch Gen Psychiatry 62, 254-262. 
 38
Pantelis, C., Velakoulis, D., McGorry, P.D., Wood, S.J., Suckling, J., Phillips, L.J., 
Yung, A.R., Bullmore, E.T., Brewer, W., Soulsby, B., Desmond, P., McGuire, P.K., 
2003. Neuroanatomical abnormalities before and after onset of psychosis: a cross-
sectional and longitudinal MRI comparison. Lancet 361, 281-288. 
Pantelis, C., Velakoulis, D., Wood, S.J., Yucel, M., Yung, A.R., Phillips, L.J., Sun, 
D.Q., McGorry, P.D., 2007. Neuroimaging and emerging psychotic disorders: the 
Melbourne ultra-high risk studies. Int Rev Psychiatry 19, 371-381. 
Pantelis, C., Yucel, M., Wood, S.J., Velakoulis, D., Sun, D., Berger, G., Stuart, G.W., 
Yung, A., Phillips, L., McGorry, P.D., 2005. Structural brain imaging evidence for 
multiple pathological processes at different stages of brain development in 
schizophrenia. Schizophr Bull 31, 672-696. 
Phillips, L.J., Velakoulis, D., Pantelis, C., Wood, S., Yuen, H.P., Yung, A.R., 
Desmond, P., Brewer, W., McGorry, P.D., 2002. Non-reduction in hippocampal 
volume is associated with higher risk of psychosis. Schizophr Res 58, 145-158. 
Reinke, A., Martins, M.R., Lima, M.S., Moreira, J.C., Dal-Pizzol, F., Quevedo, J., 
2004. Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat 
brain. Neurosci Lett 372, 157-160. 
Riecher-Rossler, A., Aston, J., Ventura, J., Merlo, M., Borgwardt, S., Gschwandtner, 
U., Stieglitz, R.D., 2008. [The Basel Screening Instrument for Psychosis (BSIP): 
development, structure, reliability and validity]. Fortschr Neurol Psychiatr 76, 207-
216. 
Riecher-Rossler, A., Gschwandtner, U., Aston, J., Borgwardt, S., Drewe, M., Fuhr, P., 
Pfluger, M., Radu, W., Schindler, C., Stieglitz, R.D., 2007. The Basel early-detection-
of-psychosis (FEPSY)-study--design and preliminary results. Acta Psychiatr Scand 
115, 114-125. 
 39
Riecher-Rossler, A., Gschwandtner, U., Borgwardt, S., Aston, J., Pfluger, M., 
Rossler, W., 2006. Early detection and treatment of schizophrenia: how early? Acta 
Psychiatr Scand Suppl, 73-80. 
Riecher-Rossler, A., Pflueger, M.O., Aston, J., Borgwardt, S.J., Brewer, W.J., 
Gschwandtner, U., Stieglitz, R.D., 2009. Efficacy of Using Cognitive Status in 
Predicting Psychosis: A 7-Year Follow-Up. Biol Psychiatry. 
Shenton, M.E., Dickey, C.C., Frumin, M., McCarley, R.W., 2001. A review of MRI 
findings in schizophrenia. Schizophr Res 49, 1-52. 
Siever, L.J., Davis, K.L., 2004. The pathophysiology of schizophrenia disorders: 
perspectives from the spectrum. Am J Psychiatry 161, 398-413. 
Siever, L.J., Koenigsberg, H.W., Harvey, P., Mitropoulou, V., Laruelle, M., Abi-
Dargham, A., Goodman, M., Buchsbaum, M., 2002. Cognitive and brain function in 
schizotypal personality disorder. Schizophr Res 54, 157-167. 
Smieskova, R., Fusar-Poli, P., Allen, P., Bendfeldt, K., Stieglitz, R.D., Drewe, J., 
Radu, E.W., McGuire, P.K., Riecher, A., Borgwardt, S.J., 2009. The effects of 
antipsychotics on the brain: What have we learnt from structural neuroimaging of 
schizophrenia? - A systematic review. Current Pharmaceutical Design 15, 2535-2549. 
Steen, R.G., Mull, C., McClure, R., Hamer, R.M., Lieberman, J.A., 2006. Brain 
volume in first-episode schizophrenia: systematic review and meta-analysis of 
magnetic resonance imaging studies. Br J Psychiatry 188, 510-518. 
Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P.D., Wood, S.J., van Erp, 
T.G., Thompson, P.M., Toga, A.W., Cannon, T.D., Pantelis, C., 2009. Progressive 
brain structural changes mapped as psychosis develops in 'at risk' individuals. 
Schizophr Res 108, 85-92. 
 40
Takahashi, T., Wood, S.J., Yung, A.R., Phillips, L.J., Soulsby, B., McGorry, P.D., 
Tanino, R., Zhou, S.Y., Suzuki, M., Velakoulis, D., Pantelis, C., 2009a. Insular cortex 
gray matter changes in individuals at ultra-high-risk of developing psychosis. 
Schizophr Res 111, 94-102. 
Takahashi, T., Wood, S.J., Yung, A.R., Soulsby, B., McGorry, P.D., Suzuki, M., 
Kawasaki, Y., Phillips, L.J., Velakoulis, D., Pantelis, C., 2009b. Progressive gray 
matter reduction of the superior temporal gyrus during transition to psychosis. Arch 
Gen Psychiatry 66, 366-376. 
Thompson, K.N., Phillips, L.J., Komesaroff, P., Yuen, H.P., Wood, S.J., Pantelis, C., 
Velakoulis, D., Yung, A.R., McGorry, P.D., 2007. Stress and HPA-axis functioning in 
young people at ultra high risk for psychosis. J Psychiatr Res 41, 561-569. 
Thompson, P.M., Hayashi, K.M., Sowell, E.R., Gogtay, N., Giedd, J.N., Rapoport, 
J.L., de Zubicaray, G.I., Janke, A.L., Rose, S.E., Semple, J., Doddrell, D.M., Wang, 
Y., van Erp, T.G., Cannon, T.D., Toga, A.W., 2004. Mapping cortical change in 
Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 Suppl 1, 
S2-18. 
Tsuang, M.T., Stone, W.S., Faraone, S.V., 2000. Towards the prevention of 
schizophrenia. Biol Psychiatry 48, 349-356. 
Tsuang, M.T., Stone, W.S., Faraone, S.V., 2002. Understanding predisposition to 
schizophrenia: toward intervention and prevention. Can J Psychiatry 47, 518-526. 
van Erp, T.G., Saleh, P.A., Huttunen, M., Lonnqvist, J., Kaprio, J., Salonen, O., 
Valanne, L., Poutanen, V.P., Standertskjold-Nordenstam, C.G., Cannon, T.D., 2004. 
Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry 61, 346-353. 
van Haren, N.E., Picchioni, M.M., McDonald, C., Marshall, N., Davis, N., Ribchester, 
T., Hulshoff Pol, H.E., Sharma, T., Sham, P., Kahn, R.S., Murray, R., 2004. A 
 41
controlled study of brain structure in monozygotic twins concordant and discordant 
for schizophrenia. Biol Psychiatry 56, 454-461. 
Velakoulis, D., Wood, S.J., Wong, M.T., McGorry, P.D., Yung, A., Phillips, L., 
Smith, D., Brewer, W., Proffitt, T., Desmond, P., Pantelis, C., 2006. Hippocampal and 
amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance 
imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk 
individuals. Arch Gen Psychiatry 63, 139-149. 
Vita, A., De Peri, L., Silenzi, C., Dieci, M., 2006. Brain morphology in first-episode 
schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. 
Schizophr Res 82, 75-88. 
Walterfang, M., McGuire, P.K., Yung, A.R., Phillips, L.J., Velakoulis, D., Wood, 
S.J., Suckling, J., Bullmore, E.T., Brewer, W., Soulsby, B., Desmond, P., McGorry, 
P.D., Pantelis, C., 2008. White matter volume changes in people who develop 
psychosis. Br J Psychiatry 193, 210-215. 
Whalley, H.C., Simonotto, E., Moorhead, W., McIntosh, A., Marshall, I., Ebmeier, 
K.P., Owens, D.G., Goddard, N.H., Johnstone, E.C., Lawrie, S.M., 2006. Functional 
imaging as a predictor of schizophrenia. Biol Psychiatry 60, 454-462. 
Whyte, M.C., Brett, C., Harrison, L.K., Byrne, M., Miller, P., Lawrie, S.M., 
Johnstone, E.C., 2006. Neuropsychological performance over time in people at high 
risk of developing schizophrenia and controls. Biol Psychiatry 59, 730-739. 
Witthaus, H., Brune, M., Kaufmann, C., Bohner, G., Ozgurdal, S., Gudlowski, Y., 
Heinz, A., Klingebiel, R., Juckel, G., 2008. White matter abnormalities in subjects at 
ultra high-risk for schizophrenia and first-episode schizophrenic patients. Schizophr 
Res 102, 141-149. 
 42
Wood, S.J., Berger, G., Velakoulis, D., Phillips, L.J., McGorry, P.D., Yung, A.R., 
Desmond, P., Pantelis, C., 2003. Proton magnetic resonance spectroscopy in first 
episode psychosis and ultra high-risk individuals. Schizophr Bull 29, 831-843. 
Wood, S.J., Yucel, M., Velakoulis, D., Phillips, L.J., Yung, A.R., Brewer, W., 
McGorry, P.D., Pantelis, C., 2005. Hippocampal and anterior cingulate morphology 
in subjects at ultra-high-risk for psychosis: the role of family history of psychotic 
illness. Schizophr Res 75, 295-301. 
Wright, I.C., Rabe-Hesketh, S., Woodruff, P.W., David, A.S., Murray, R.M., 
Bullmore, E.T., 2000. Meta-analysis of regional brain volumes in schizophrenia. Am 
J Psychiatry 157, 16-25. 
Yucel, M., Wood, S.J., Phillips, L.J., Stuart, G.W., Smith, D.J., Yung, A., Velakoulis, 
D., McGorry, P.D., Pantelis, C., 2003. Morphology of the anterior cingulate cortex in 
young men at ultra-high risk of developing a psychotic illness. Br J Psychiatry 182, 
518-524. 
Yung, A.R., Nelson, B., Stanford, C., Simmons, M.B., Cosgrave, E.M., Killackey, E., 
Phillips, L.J., Bechdolf, A., Buckby, J., McGorry, P.D., 2008. Validation of 
"prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year 
follow-up. Schizophr Res 105, 10-17. 
Yung, A.R., Phillips, L.J., McGorry, P.D., McFarlane, C.A., Francey, S., Harrigan, S., 
Patton, G.C., Jackson, H.J., 1998. Prediction of psychosis. A step towards indicated 
prevention of schizophrenia. Br J Psychiatry Suppl 172, 14-20. 
Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S.M., McFarlane, C.A., Hallgren, M., 
McGorry, P.D., 2003. Psychosis prediction: 12-month follow up of a high-risk 
("prodromal") group. Schizophr Res 60, 21-32. 
 43
Yung, A.R., Phillips, L.J., Yuen, H.P., McGorry, P.D., 2004. Risk factors for 
psychosis in an ultra high-risk group: psychopathology and clinical features. 
Schizophr Res 67, 131-142. 
Yung, A.R., Yuen, H.P., Berger, G., Francey, S., Hung, T.C., Nelson, B., Phillips, L., 
McGorry, P., 2007. Declining transition rate in ultra high risk (prodromal) services: 
dilution or reduction of risk? Schizophr Bull 33, 673-681. 
Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., 
Francey, S.M., Cosgrave, E.M., Killackey, E., Stanford, C., Godfrey, K., Buckby, J., 
2005. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk 
Mental States. Aust N Z J Psychiatry 39, 964-971. 
Zilles, K., Armstrong, E., Schleicher, A., Kretschmann, H.J., 1988. The human 
pattern of gyrification in the cerebral cortex. Anat Embryol (Berl) 179, 173-179. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44
TABLE AND FIGURE LEGENDS 
 
TABLE 1: Selection criteria employed to define clinical high-risk groups  
TABLE 2: Neuroimaging studies included in the review 
TABLE 3: Structural imaging studies of individuals at high-risk of psychosis  
TABLE 4: Meta-analysis of structural findings  
TABLE 5: Neurofunctional imaging studies of individuals at high-risk of psychosis 
TABLE 6: Meta-analysis of functional findings  
 
FIGURE 1: Flowchart of the studies considered and included according to the design 
